Haemonetics 1st Quarter Fiscal 2019 Earnings Release Available on Investor Relations Website
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Haemonetics (HAE) Tops Q1 EPS by 17c, Revenues Beat
August 7, 2018 6:21 AM EDTHaemonetics (NYSE: HAE) reported Q1 EPS of $0.59, $0.17 better than the analyst estimate of $0.42. Revenue for the quarter came in at $229.3 million versus the consensus estimate of $219.95 million.
GUIDANCE:
Haemonetics sees FY2019 EPS of $2.00-$2.30, versus the consensus of $2.17.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
... More